Home › Cardiovascular Disease › Nebraska
Cardiovascular Disease clinical trials in Nebraska
10 studies for Cardiovascular Disease are looking for participants at sites in Nebraska.
Cities in Nebraska
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- CHI Health Nebraska Heart, Grand Island
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
- and 1 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Product Surveillance Registry
- Omaha
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Fremont
- Clinical Trial Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Nebraska Medical Center, Omaha
- Omaha VA Medical Center, Omaha
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Elkhorn
- Research Site, Fremont
- Research Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Bryan Heart, Lincoln
- Physician Research Collaboration, LLC, Lincoln
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT05931276From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.